ECM
JAZZ icon

EMC Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

EMC Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$468K Sell
2,751
-486
-15% -$74.5K 0.21% 25
2025
Q3 		$427K Hold
3,237
– – 0.2% 29
2025
Q2 		$344K Buy
+3,237
New +$352K 0.19% 28

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EMC Capital Management's JAZZ Position: Q4 2025 in Review

EMC Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q4 2025, selling an estimated $74.5K and leaving 2,751 shares worth $468K. The position accounts for 0.21% of the portfolio, ranked #25.

EMC Capital Management first reported a position in JAZZ in Q2 2025 and has held it in 3 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • EMC Capital Management held 2,751 shares of Jazz Pharmaceuticals worth $468K as of Q4 2025.
  • EMC Capital Management sold 486 Jazz Pharmaceuticals shares in Q4 2025, an estimated $74.5K.
  • Jazz Pharmaceuticals made up 0.21% of EMC Capital Management's portfolio in Q4 2025, its #25 holding.
  • EMC Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.